Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS)
Treatment of Post-Chemotherapy Cognitive Impairment With Transcranial Magnetic Stimulation (Chemobrain TMS)
Sponsor: University of Arizona
Terminated
Stopped due to the risk of COVID-19 variants to our subject base of cancer patients
Listed as NCT04295720, this NA trial focuses on Chemo-brain and remains terminated or withdrawn. Sponsored by University of Arizona, it has been updated 10 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2023 — Jul 2024 [monthly]
Terminated NA
-
Sep 2022 — Apr 2023 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 5 earlier versions
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
-
Apr 2020 — Jun 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Arizona
For direct contact, visit the study record on ClinicalTrials.gov .